Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Endocrinological Investigation
|
April 1, 1994
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K
P Beck-Peccoz, V K Chatterjee, W W Chin, et al.
Endocrine Connections
|
February 12, 2016
Mild cold effects on hunger, food intake, satiety and skin temperature in humans
M Langeveld, C Y Tan, M R Soeters, et al.
Clinical Endocrinology
|
July 1, 2016
Molecular spectrum of TSHβ subunit gene defects in central hypothyroidism in the UK and Ireland
A K Nicholas, S Jaleel, G Lyons, et al.
The Journal of Clinical Investigation
|
January 31, 1998
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
M Adams, C T Montague, J B Prins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 14, 2006
Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype
N Manji, J D Carr-Smith, K Boelaert, et al.
The Journal of Biological Chemistry
|
February 22, 2000
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis
M Gurnell, J M Wentworth, M Agostini, et al.
Nature
|
January 6, 2000
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
I Barroso, M Gurnell, V E Crowley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 1997
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators
T N Collingwood, O Rajanayagam, M Adams, et al.
Endocrinology
|
December 1, 1999
Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone
M Gurnell, O Rajanayagam, M Agostini, et al.
Seminars in Oncology
|
September 29, 2018
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab
R T Casey, O Giger, I Seetho, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Endocrinological Investigation
|
April 1, 1994
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K
P Beck-Peccoz, V K Chatterjee, W W Chin, et al.
Endocrine Connections
|
February 12, 2016
Mild cold effects on hunger, food intake, satiety and skin temperature in humans
M Langeveld, C Y Tan, M R Soeters, et al.
Clinical Endocrinology
|
July 1, 2016
Molecular spectrum of TSHβ subunit gene defects in central hypothyroidism in the UK and Ireland
A K Nicholas, S Jaleel, G Lyons, et al.
The Journal of Clinical Investigation
|
January 31, 1998
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
M Adams, C T Montague, J B Prins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 14, 2006
Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype
N Manji, J D Carr-Smith, K Boelaert, et al.
The Journal of Biological Chemistry
|
February 22, 2000
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis
M Gurnell, J M Wentworth, M Agostini, et al.
Nature
|
January 6, 2000
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
I Barroso, M Gurnell, V E Crowley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 1997
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators
T N Collingwood, O Rajanayagam, M Adams, et al.
Endocrinology
|
December 1, 1999
Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone
M Gurnell, O Rajanayagam, M Agostini, et al.
Seminars in Oncology
|
September 29, 2018
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab
R T Casey, O Giger, I Seetho, et al.
Page
of 8